PERSPECTA

News from every angle

← Back to headlines

Viridian Therapeutics Stock Surges 75% Despite Fund Selling Stake

Viridian Therapeutics stock surged by 75%, even as one fund divested its $69 million stake in the company.

23 Feb, 15:46 — 23 Feb, 15:46
PostShare
Only 1 source covers this story